Meister, & Hinz, 2007) . The latent TGF-β in the ECM is believed to serve as a mechanosensor molecule, which transduces mechanical cues at cell surface into intracellular signals to control cellular differentiation (Hinz, 2009 ).
The role of latent TGF-β as a mechanosensor is best illustrated in wound healing process. After tissue injury, latent TGF-β can be activated to drive tissue remodeling (Hinz, 2015; Wan et al., 2012) .
Specifically, TGF-β promotes the differentiation of precursor cells into fibrogenic myofibroblasts (Amara et al., 2010; Hecker et al., 2009; Meyer-Ter-Vehn, Katzenberger, Han, Grehn, & Schlunck, 2008) . Myofibroblasts function to secrete ECM to promote fibrosis at the wound and contract the ECM to accelerate wound closure (Darby, Laverdet, Bonté, & Desmoulière, 2014; Hecker et al., 2009 ).
Intravenous injection of TGF-β1 can accelerate the wound healing in rat's tongue (El Gazaerly, Elbardisey, Eltokhy, & Teaama, 2013) , while in the absence of TGF-β1 or in the presence of TGF-β inhibition the wound healing process is impaired (Crowe, Doetschman, & Greenhalgh, 2000; Wang et al., 2017) .
TGF-β-induced reactive oxygen species (ROS) have been functionally implicated in different cellular processes, such as myofibroblast differentiation under fibrogenic conditions (Amara et al., 2010; Jiang, Liu, Dusting, & Chan, 2014) , epithelial-mesenchymal transition (EMT; Boudreau et al., 2012; Rhyu et al., 2005) , and cytoskeleton reorganization (Hu et al., 2005) . Although in some studies, TGF-β may promote ROS production in mitochondria by affecting electron transport complex activity (Casalena, Daehn, & Bottinger, 2012; Jain et al., 2013) , NADPH oxidases (Nox) are responsible for TGF-β-induced cellular ROS in other cases (Boudreau et al., 2012; Hecker et al., 2009; Hu et al., 2005) . Nox4 gene expression is found to be induced by TGF-β and is required for TGF-β-mediated myofibroblast activation and fibrogenesis (Hecker et al., 2009; Sampson et al., 2009 ). Therefore, TGF-β-dependent ROS production can be a therapeutic target for pathophysiological fibrosis.
Our recent study demonstrates a direct role of endogenous β-actin level in regulating the biophysical features at the cell surface (Xie, Deliorman, Qasaimeh, & Percipalle, 2018) . We wondered whether the altered biophysical feature affects TGF-β signaling in β-actin null cells, since mechanical force at the cell surface can activate latent TGF-β. Indeed, when we compared the transcriptomes between wild-type (WT) β-actin +/+ and knockout (KO) β-actin −/− mouse embryonic fibroblasts (MEFs), TGF-β1 signaling pathway was identified as an upstream activator for expression changes of certain genes in the KO cells. Different classes of TGF-β1 target genes were upregulated in the KO cells. The elevated TGF-β1 signaling activation in the KO cells seems to be caused by the efficient activation and utilization of latent TGF-β1, while Tgfb1 gene was expressed at a comparable level between WT and KO cells. We further demonstrated that TGF-β-dependent cellular ROS production is required for the enhanced myofibroblast features of the KO cells, which is likely to be mediated by the upregulation of Nox4 gene.
However, other gene programs and angiogenic features of the KO cells were not affected after TGF-β inhibition. Our data, together with our recent finding that WT and KO cells exhibit major differences in cell surface mechanical properties (Xie et al., 2018) , suggest that the enhanced TGF-β1 activation in the KO cells is likely due to the altered biophysical properties at the cell surface. The elevated TGF-β activation contributes to the enhanced myofibroblast features of the β-actin null cells, without affecting other gene programs or cellular features. Collectively, our study shows a scenario that after genetic reprograming of the actin cytoskeleton, the alterations in cellular biophysical features result in the change in signaling process to affect cellular phenotype.
| MATERIALS AND METHODS

| Antibodies and reagents
Antibodies of myosin light chain 9 (Myl9; ab64161), Itga11 (ab198826)
were from Abcam (Cambridge, UK). Antibodies against β-actin (clone AC-74), diphenyleneiodonium chloride (DPI; D2926), SB431542 hydrate Anti-GAPDH-HRP (HRP-60004) was from ProSci (Fort Collins, CO).
Mouse TGF Beta 1 PicoKine™ ELISA Kit was from BosterBio (Pleasanton, CA).
| Cell culture
β-Actin +/+ WT MEFs and β-actin −/− KO MEFs were maintained in DMEM with high glucose (Sigma-Aldrich), supplemented with 10% FBS (Sigma-Aldrich) and 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma-Aldrich), in a humidified incubator with 5% CO 2 at 37°C. For certain experiments, serum-free DMEM was used as specified.
2.3 | CellROX staining analysis using high-content screening (HCS) platform 
| RNA-seq analysis data
Detailed RNA-seq analysis was described in Xie et al. (2017) . RNA-seq data were deposited in GEO repository, and the GEO accession number is GSE95830. Ingenuity pathway analysis (Qiagen Bioinformatics, Redwood City, CA) was used to predict the upstream regulators based on the changes of differentially expressed genes (adjusted p < 0.05, with fold change ≥2) between WT and KO MEFs.
| Western blot analysis
The cell lysate was harvested using RIPA buffer and protein concentrations were quantified by BCA Protein Assay Kit (Thermo Fisher Scientific). Samples were mixed with 2× Laemmli sample buffer (Sigma-Aldrich) and heated at 95°C for 5 min. Immunoblotting was done using anti-Myl9 (1:1000), anti-Itga11 (1:800),
anti-α-smooth muscle actin (α-SMA; 1:1000), anti-β-actin (1:1500), ) were cultured at confluence in 350 µl serumfree DMEM or DMEM containing 10% FBS for 24 hr. TGF-β1 levels in the medium were determined using Mouse TGF Beta 1 PicoKine™ ELISA Kit (BosterBio) according to the manufacturer's protocol.
Briefly, 100 µl cell culture supernatant was activated with 20 µl of 1 M HCl for 10 min at room temperature, followed by pH neutralization with 1.2 M NaOH-0.5 M HEPES. The activated supernatant (100 µl) was added to 96-well plate precoated with anti-TGF-β1 antibody and incubated at 37°C for 90 min. The supernatant was discarded and 100 µl of biotinylated anti-TGF-β1
antibody was added to each sample for 60 min incubation at 37°C.
Contents in the plate were discarded and the plate was washed three times with PBS, followed by incubation with 100 µl ABC working solution for 30 min at 37°C. After five times wash with PBS, 90 µl TMB color-developing agent was added. After 30 min of incubation at 37°C, the reaction was terminated by the addition of 100 µl stop solution. Absorbance at 450 nm was recorded using Synergy H1 microplate reader (BioTek, Dubai, U.A.E). TGF-β1 concentration was extracted based on the standard curve of recombinant TGF-β1. were seeded and allowed to be grown confluent in 24-well plate for 24 hr. 0.1 M acetic acid (250 µl) was added to each well to solubilize the extracellular collagen, with a gentle shake for 30 min at room temperature. Both supernatant and cell debris were collected and centrifuged at 10,000 rpm for 5 min. Then, 100 µl supernatant was mixed with 500 µl Sirius Red dye for 20 min at room temperature.
| Floating collagen gel contraction assay
After centrifugation at 10,000 rpm for 5 min, the red pellet was dissolved in 250 µl extraction buffer and measured at optical density 530 nm using Synergy H1 microplate reader (BioTek).
| Dual luciferase assay
Plasmids pRL-SV40P (control vector), SBE4-Luc, and FBE/SBE-Luc were purchased from Addgene (Cambridge, MA). 1 × 10 4 MEF cells were seeded in a 96-well plate. Cells were transfected with 100 ng pRL-SV40P
and 200 ng of SBE4-Luc or 200 ng of FBE/SBE-Luc using TurboFect transfection reagent (Thermo Fisher Scientific) in a serum-free medium.
Forty-eight hours posttransfection in the serum-free medium, the dual luciferase assay was performed using Pierce Renilla-Firefly Luciferase 2.13 | 3-(4,5-Dimethylthiazol-2-yl)-2, 5 -diphenyltetrazolium bromide (MTT) assay
MTT assay was performed as described in Xie, Wang, Wong, and Fung (2013) . Six thousand cells per well were seeded in the 96-well plate.
Cells were treated with chemicals at varying concentration for 18 hr.
MTT reagent (16 μl, 5 mg/ml; Sigma-Aldrich) was added to each well and incubated at 37°C for 3 hr. Culture medium was aspirated and 120 μl dimethyl sulfoxide was added to each well for 10-min incubation at room temperature. Absorbance was measured at a wavelength of 570 nm by Synergy H1 microplate reader (BioTek, Dubai, U.A.E).
| Statistical analysis
All experimental data are expressed as mean ± SEM. Statistical difference and significance between the groups were determined by either Student's t test or one-way analysis of variance using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA).
3 | RESULTS 3.1 | In β-actin KOs, elevated TGF-β signaling results from the active utilization of latent TGF-β1
We have recently shown that the transcriptome of β-actin −/− KO MEFs exhibit significant changes of gene expression programs in comparison with the β-actin +/+ WT MEFs (Xie et al., 2017) . To identify the potential upstream regulators that may be responsible for controlling subsets of genes or gene programs, we analyzed differentially expressed genes (at least two-fold change, adjusted p < 0.05) between WT and KO cells using an Ingenuity Pathway Analysis software. The implemented upstream analysis tool predicts activation or inhibition of upstream transcription factors or signaling pathways based on the gene expression changes (Krämer, Green, Pollard, & Tugendreich, 2014) .
Among the top 10 upstream regulators identified, TGF-β1 (TGFB1), SMAD3, TGF-β receptor 1 (TGFBR1) and SMAD4 are predicted to be Xu, Lamouille, & Derynck, 2009; Yu et al., 2008) . These genes include Tmsb4x, Tagln, Actn1, and Msn that are involved in cytoskeleton function (Ranganathan et al., 2007; Yu et al., 2008) ; Fn1, Ctcf, Col1a1, and Lox that are components or regulators in ECM formation (Fang et al., 2016; O'Callaghan & Williams, 2000; Ranganathan et al., 2007) ;
Hmga2, Snai1, and Vim that are regulator or markers in EMT (Thuault et al., 2006; Xu et al., 2009); and Gsk3b, Plcb4, Wnt5a, and Cdk1a (p21) which function in different cellular signaling processes (Datto et al., 1995; Ranganathan et al., 2007) . To confirm the TGF-β pathway was activated to a higher level in β-actin −/− cells, we used a previous published TGF-β luciferase reporter FBE/SBE-Luc, which contains FAST-1-binding element (FBE) adjacent to Smad-binding element (SBE; Zhou, Zawel, Lengauer, Kinzler, & Vogelstein, 1998) . The SBE-Luc serves as a negative control as it was unable to confer response to TGF-β signaling (Zhou et al., 1998) . We observed that the KO cells activated FBE/SBE-Luc construct to a significantly higher level in comparison to WT MEFs, while no difference was observed for the SBE-Luc construct ( Figure 1c) . Therefore, the KO cells show increased level of TGF-β signal activation.
To explore the possible mechanism, we quantified the TGF-β1 level in the serum-free medium with cultured cells by ELISA. To our surprise, the overall TGF-β1 level is much lower in the medium with the KO cells than that of the WT cells (Figure 1d ).
The lower level of TGF-β1 is not due to the reduced Tgfb1 gene expression in the KO cells (Figure 1f and Supporting Information Figure S1A ). Although TGF-β1 receptor gene (Tgfbr1) is upregulated in the KO cells (Figure 1f and Supporting Information Figure S1B ), it is well established that TGF-β is produced as latent, high-molecular-weight complex that needs to be activated before receptor binding (Hinz, 2015; Shi et al., 2011) . Therefore, , were also found to express at significantly higher level in the KO cells (Supporting Information Figure S1C -E).
| TGF-β-dependent Nox4 upregulation contributes to ROS production in the absence of β-actin
It is known that TGF-β1 induces ROS production and ROS mediates some of TGF-β effects such as TGF-β-induced fibrosis (Liu & Desai, 2015) . We, therefore, analyzed the oxidative status between WT and KO cells by CellROX Deep Red dye, which exhibits fluorescence upon ROS oxidation and can be quantified after fixation. The HCS platform was used for automated image quantification. The nuclear region of Therefore, the elevated cellular ROS levels in the KO cells are not due to the increased mitochondrial superoxide production.
Nox are a family of enzymes responsible for intracellular ROS production under a variety of pathophysiological conditions (Guichard et al., 2006) . Nox4 gene is found to be induced by TGF-β in different cell types (Boudreau et al., 2012; Hecker et al., 2009; Yan et al., 2014) . We, 3.3 | TGF-β signaling contributes to myofibroblast feature in the absence of β-actin
Our recent study shows that β-actin KOs display myofibroblast features, including enhanced abilities to produce and contract ECM (Xie et al., 2017) . Since Nox4 induced by TGF-β mediates myofibroblast differentiation (Hecker et al., 2009; Jiang et al., 2014) , and then plated on extracellular matrix gel in complete DMEM in the presence of SB431542 (8 µM, 24 hr). DMEM, Dulbecco's modified Eagle's medium; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Itga11, integrin α11; KO, knockout; Myl9, myosin light chain 9; ns, not significant; TGF-β, transforming growth factor-β; WT, wild type; α-SMA, α-smooth muscle actin Hinz, 2009; Zinski et al., 2017) . In this study, through a comparative analysis of the transcriptomes of WT (β-actin +/+ ) and KO (β-actin
MEFs, we identified TGF-β1 signaling pathway as upstream regulator which is activated in the absence of β-actin to induce the upregulation of a group of its target genes. This finding is consistent with a proteomic study in which TGF-β1 is predicted to be a potential upstream activator for overexpressed actin-binding proteins in the β-actin KOs (Ampe, Libbrecht, & van Troys, 2013) . However, our results indicate that the enhanced TGF-β activation observed in the KO cells is caused by the active utilization of the latent TGF-β1 in the culture medium instead of upregulating Tgfb1 gene. TGF-β is secreted as part of a latent protein complex and acts as an extracellular mechanosensor to switch on fibrosis (Duscher et al., 2014; Hinz, 2015) . Latent TGF-β is tethered to the ECM by LTBPs, which can be released and activated by the cell surface mechanical force transmitted via integrins (Annes et al., 2004; Buscemi et al., 2011; Shi et al., 2011) . We recently reported that β-actin KO cells exhibit dramatic changes in their biophysical properties at cell surface, including increased elasticity and adhesion to the probe as revealed by atomic force microscopy (Xie et al., 2018) . We, therefore, conclude that in the absence of β-actin the augmented activation and utilization of latent TGF-β is likely due to the altered biomechanical properties at the cell surface.
In many fibrogenic responses and EMT processes, ROS production plays an important role in mediating the effect of TGF-β signaling (Hagler et al., 2013; Jiang et al., 2014; Liu & Desai, 2015; Rhyu et al., 2005) . The origin of ROS induced by TGF-β activation may differ under different conditions (Liu & Desai, 2015) . In some studies, ROS generated by mitochondrial electron transport chain complexes are reported to be responsible for TGF-β-mediated effects (Casalena et al., 2012; Jain et al., 2013) . In other cases, ROS generated by Nox contributes to TGF-β-dependent cellular processes (Amara et al., 2010; Hiraga, Kato, Miyagawa, & Kamata, 2013; Hu et al., 2005; Liu & Desai, 2015 are consistent with previous studies in which Nox4 expression is found to be upregulated by TGF-β and where Nox4-derived ROS levels are found to mediate fibroblast to myofibroblast transdifferentiation (Hecker et al., 2009; Jiang et al., 2014; Sampson et al., 2009) . Therefore, our study supports the model whereby TGF-β signaling activation in the KO cells induces Nox4 expression and Nox4-derived ROS contributes to the enhanced myofibroblast features.
Seeing that in the absence of β-actin several gene programs were found to exhibit altered expression (Xie et al., 2017) , we further investigated whether the activated TGF-β signaling contributes to other differentially expressed genes between WT and KO cells. We found that inhibition of TGF-β signaling does not affect the previously observed upregulation of actin cytoskeleton and integrin genes in the KO cells. For example, α-SMA is a marker in myofibroblast differentiation which can be rapidly induced by TGF-β (Hecker et al., 2009; Thannickal et al., 2003) .
However, in the KO cells, the heavily upregulated α-SMA (Acta2) is not affected after TGF-β inhibitor treatment. Moreover, the augmented angiogenic properties are not affected after inhibition of TGF-β signaling.
These results indicate that in the absence of β-actin, TGF-β signaling activation does not contribute to the core gene programs implicated in the actin cytoskeleton and integrin genes or in angiogenesis. These core gene programs altered in the KO cells are due to the global chromatin change in the absence of nuclear β-actin (Xie et al., 2017) . Collectively, our data support the idea that the observed activation of TGF-β signaling in the KO cells is a consequence of the altered biophysical features at cell surface after actin isoform switching and the actin cytoskeleton reorganization (Xie et al., 2018) . The enhanced TGF-β signaling and elevated cellular ROS production then contribute to augmenting the myofibroblast features in the β-actin KO cells.
In summary, we found that in the cells lacking β-actin, elevated 
